Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Thoracic 1Sarcoma 1Gynecologic 1

Conditions

Sarcoma 16Osteosarcoma 10Carcinosarcoma 9Neoplasm Metastasis 8Rhabdomyosarcoma 7Neuroblastoma 7Melanoma 6Lymphoma, Non-Hodgkin 6Endometrial Neoplasms 6Wilms Tumor 5Sarcoma, Ewing 5Rhabdoid Tumor 5Ovarian Neoplasms 5Lung Neoplasms 5Liposarcoma 5Leiomyosarcoma 5Histiocytosis, Langerhans-Cell 5Hepatoblastoma 5Gliosarcoma 5Glioblastoma 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Non-Small-Cell Lung 5Carcinoma, Hepatocellular 5Sarcoma, Kaposi 4Neuroectodermal Tumors, Primitive, Peripheral 4Medulloblastoma 4Histiocytoma, Malignant Fibrous 4Glioma 4Ependymoma 4

Interventions

tislelizumab 2Nivolumab 2Magnetic Resonance Spectroscopy 2Irinotecan 2Erlotinib Hydrochloride 2trastuzumab deruxtecan 1spartalizumab 1regorafenib 1entinostat 1Thalidomide 1Specimen Handling 1Serotonin Plasma Membrane Transport Proteins 1Ritonavir 1Radiotherapy 1Radionuclide Imaging 1Quality of Life 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Paclitaxel 1Oxaliplatin 1Observation 1Molecular Diagnostic Techniques 1Mesna 1Leucovorin 1Ipilimumab 1Indinavir 1Immunotherapy 1Ifosfamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anus Neoplasms × Specimen Handling × Sarcoma × Clear all
NCT02408861 2026-01-21

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1 Terminated
79 enrolled 24 charts
GastrointestinalSarcomaThoracic

Anus Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡